Seminars in Diagnostic Pathology
Volume 20, Issue 2 , Pages 105-120, May 2003

Splenic involvement by peripheral T-cell and NK-cell neoplasms

  • John K.C Chan, MD

      Affiliations

    • Department of Pathology, Queen Elizabeth Hospital, Hong Kong, S.A.R. China
    • Corresponding Author InformationAddress reprint requests to John K.C. Chan, MD, Department of Pathology, Queen Elizabeth Hospital, Wylie Road, Kowloon, Hong Kong, S.A.R. China

Article Outline

Abstract 

In contrast to B-cell lymphomas, the literature on the splenic pathology of peripheral T-cell and NK-cell lymphomas is limited. Several different patterns of splenic involvement can be observed in peripheral T-cell and NK-cell lymphomas: 1) solitary or multiple fleshy nodule, which is seen predominantly in tumors rich in large cells; 2) diffuse red pulp involvement, which is the commonest pattern; 3) colonization of periarteriolar shealth; and 4) patchy haphazard involvement. However, the miliary small nodule pattern commonly observed in low-grade B-cell lymphomas is practically never seen. In hepatosplenic T-cell lymphoma and T-cell large granular lymphocyte leukemia, the pattern of splenic involvement is rather stereotyped, with diffuse red pulp infiltration and preservation of the sinus/pulp cord architecture, and without formation of nodules. The pattern of involvement is variable from case to case in peripheral T-cell lymphoma unspecified, and there can be associated prominent hemophagocytosis or a masking component of epithelioid granulomas. Aggressive NK cell leukemia and extranodal NK/T cell lymphoma show predominatly red pulp involvement, although the tumor cell density can vary from field to field; blood vessel walls are commonly infiltrated and there can be areas of necrosis.

Keywords:  Spleen, splenic lymphoma, T-cell lymphoma, NK-cell lymphoma

 

Back to Article Outline

Overview on patterns of splenic involvement in peripheral T-cell and NK-cell lymphoid neoplasms 

THE MORPHOLOGIC PATTERNS of splenic involvement by B-cell lymphomas have been quite well studied. Small B-cell lymphomas, such as grade 1 or 2 follicular lymphoma, mantle cell lymphoma and marginal zone B-cell lymphoma, typically replace and expand the white pulp Malpighian corpuscles, with variable spillover into the red pulp. Large B-cell lymphomas often form solitary or multiple large tumor nodules, although they may also rarely involve the red pulp in a diffuse pattern. In contrast, information on the morphologic patterns of splenic involvement by peripheral T-cell and NK-cell lymphoid neoplasms is meager. Even hematopathology book chapters and textbooks on splenic pathology devote only short paragraphs on such pathologic changes.1, 2, 3 The reasons are as follows:

1.Peripheral T-cell and NK-cell lymphomas are much less common compared with B-cell lymphomas. According to the Non-Hodgkin Lymphoma Classification Project, peripheral T-cell and NK-cell lymphomas account for only 10% of all non-Hodgkin lymphomas.4 In a retrospective analysis of the personal consultation files (1983 through 1993) of Dr Henry Rappaport, 108 spleens involved by non-Hodgkin lymphoma were identified, including 43 primary splenic lymphomas, 58 cases of secondary splenic involvement, and 7 cases of hairy cell leukemia.5 Among them, there are only 5 cases of peripheral T-cell lymphoma unspecified and one case of T-cell large granular lymphocyte leukemia. In a review of 1,280 splenectomy specimens encountered over a 10-year period in two tertiary care institutions, there were 130 cases of B-cell lymphoma, but only 6 cases of peripheral T-cell lymphoma.6

2.Immunophenotypic data were not available in the era when splenectomy was commonly performed as part of the staging procedure for lymphomas. However, now that comprehensive immunophenotyping can be readily applied even on paraffin-embedded tissues, splenectomy is rarely performed in patients with known lymphoma except when splenomegaly causes symptoms or complications.

The patterns of splenic involvement by peripheral T-cell and NK-cell neoplasms are variable, and are listed in Table 1. 3, 7 The miliary small nodule pattern produced by selective white pulp involvement, while common in small B-cell lymphomas, is practically never seen in peripheral T-cell and NK-cell neoplasms. A synopsis is presented in Table 2.

Table 1. Commoner Patterns of Splenic Involvement by Peripheral T Cell and NK Cell Lymphomas/Leukemias
Solitary or multiple fleshy nodules
Diffuse red pulp involvement with or without micronodule formation
Colonization of periarteriolar sheath∗
Patchy haphazard involvement

∗ This can occur as a sole pattern, or more commonly occurs in combination with the other three listed patterns

Table 2. A Synopsis of Splenic Involvement by Peripheral T-Cell or NK-Cell Lymphoma
Knowledge of the splenic pathology in peripheral T-cell and NK-cell lymphomas is limited.
It is not possible to reliably distinguish T-cell or NK-cell lymphoma from B-cell lymphoma on morphologic grounds alone, with the exception that T- or NK-cell lymphoma is much less likely if a predominantly white pulp expansion pattern is seen. Immunohistochemical staining is required to delineate the cellular lineage.
Many different patterns of splenic involvement can be seen in peripheral T-cell and NK-cell lymphomas, but the most common pattern is diffuse red pulp infiltration, with preservation of the sinus-pulp cord architecture.
The same type of peripheral T-cell or NK-cell lymphoma can produce different histologic patterns of involvement in the spleen, with the exception of hepatosplenic T-cell lymphoma and T-cell large granular lymphocyte leukemia, which show fairly stereotypic histologic features
While angioinvasion and necrosis are characteristic of NK-cell neoplasms, they are by no means specific, because they also be observed in conventional peripheral T-cell lymphomas or even B-cell lymphomas.

Solitary or multiple large fleshy nodules 

Some peripheral T-cell lymphomas produce a solitary tumor nodule or multiple separate or coalescent nodules in the spleen. These nodules are often fleshy and tan-white, and necrosis is common. Histologically, the neoplastic cells form compact sheets, causing total destruction of the normal splenic parenchyma in the affected areas (Fig 1). This pattern of involvement is seen predominantly in peripheral T-cell lymphoma unspecified rich in large cells and T/null-cell anaplastic large cell lymphoma.

  • View full-size image.
  • Fig 1. 

    Anaplastic large cell lymphoma involving spleen in the form of a solitary large nodule. Histologically, sheets of large lymphoma cells obliterate the normal splenic architecture.

Diffuse red pulp expansion 

Diffuse involvement of the red pulp of the spleen results in a beefy red appearance on the cut surface. Histologically, the lymphoma cells infiltrate and expand the red pulp, with preservation of the splenic sinus and pulp cord framework. Preservation of the vasculature of the spleen accounts for the red color in the gross specimen. The lymphoma cells can be individually dispersed within the red pulp, or can show extensive dense infiltrate Fig 2, Fig 3. Sometimes the lymphoma cells are localized predominantly or exclusively in the pulp cord, leaving the sinuses relatively empty-looking. There can be superimposed tight nodular aggregates of lymphoma cells in the red pulp (Fig 4). The white pulp is usually atrophic or lost.

  • View full-size image.
  • Fig 3. 

    Peripheral T-cell lymphoma unspecified involving spleen with a diffuse red pulp pattern. (A) Compared with Figure 2, the lymphoma cells are more densely packed. (B) Despite the dense lymphomatous infiltration, the sinuses and pulp cords can still be identified.

  • View full-size image.
  • Fig 4. 

    Anaplastic large cell lymphoma involving spleen in a diffuse red pulp pattern with superimposed small nodules. (A) The pale-staining areas represent foci of discrete tumor nodule formation. (B) The large lymphoma cells are dispersed in the red pulp, and cellular nodules (right upper field) are also formed.

Diffuse red pulp expansion is the most common pattern of splenic involvement by peripheral T-cell and NK-cell lymphomas.5 Hepatosplenic T-cell lymphoma and T-cell large granular lymphocyte leukemia typically show this pattern of splenic involvement, while peripheral T-cell lymphoma unspecified and NK/T cell lymphoma often but not necessarily involve the spleen in this pattern.

Colonization of the periarteriolar sheath 

The periarteriolar sheath of the spleen, which is normally populated by mature T cells, is the T-zone of the spleen. In peripheral T-cell and NK-cell lymphoma involving the spleen, this sheath can be colonized by lymphoma cells (Fig 5). 7 This form of involvement may not produce visible abnormality in the gross specimen, and can be missed on casual examination of the histologic sections. Rarely, there is in addition involvement of the peripheral portion of the marginal zones.7 This pattern of splenic involvement is most commonly seen in combination with other patterns of involvement.

  • View full-size image.
  • Fig 5. 

    Peripheral T-cell lymphoma unspecified with periarteriolar sheath colonization in addition to red pulp involvement. (A) At low magnification, there are pale foci around the arterioles (arrows), representing colonization of periarteriolar sheaths by lymphoma cells. (B) Higher magnification shows presence of medium-sized and large lymphoid cells in the periarteriolar zone.

Patchy haphazard involvement 

Involvement of the spleen can take the form of focal patchy infiltration of the red pulp, without producing an obvious mass at the macroscopic level. Other areas of the spleen appear normal histologically. This pattern can be observed in occasional cases of peripheral T-cell lymphoma unspecified and NK-cell lymphoma.

Back to Article Outline

The issue of primary peripheral T-cell or NK-cell lymphoma of the spleen 

Using a strict definition, primary splenic lymphoma, defined as disease confined to the spleen and/or splenic hilar lymph nodes, is very rare. Using a lenient approach, such as acceptance of presence of bone marrow involvement, primary splenic lymphoma is not so rare.8 The majority of cases of primary splenic lymphomas are of B-lineage, with diffuse large B-cell lymphoma being the commonest.9 True primary peripheral T-cell lymphomas of the spleen (using a strict definition) are on record, but are extremely rare.6, 10, 11, 12

Back to Article Outline

Clinicopathologic features of specific types of peripheral T-cell or NK-cell lymphoid neoplasms involving the spleen 

Hepatosplenic T-cell lymphoma 

Hepatosplenic T-cell lymphoma is an uncommon but distinctive form of peripheral T-cell lymphoma characterized by uniform medium-sized lymphoma cells expressing T-lineage markers, and exhibiting prominent involvement of the spleen and liver in a sinusoidal pattern.13, 14 This entity was originally known as “hepatosplenic γδT-cell lymphoma” because of consistent expression of γδ rather than αβ T-cell receptor. Since rare cases with similar clinicopathologic and cytogenetic features are shown to express αβ T-cell receptor, the qualifier “γδ” has been dropped from the nomenclature.15, 16, 17, 18

Because of prominent splenomegaly in the absence of readily biopsied lymph nodes, the spleen is not uncommonly removed for initial pathologic diagnosis. While the spleen is always involved, it is never the sole site of disease.

Clinical features 

Hepatosplenic T-cell lymphoma most commonly occurs in young patients aged 15 to 35 years. There is marked male predominance.14 The patients present with hepatosplenomegaly, systemic symptoms, and/or thrombocytopenia. There is usually no peripheral lymphadenopathy. There can be small numbers of circulating lymphoma cells. Hepatosplenic T-cell lymphoma occasionally occurs in the setting of immunosuppression, such as organ transplant recipients.19, 20, 21, 22, 23, 24, 25 Rare association with hepatitis B infection has also been reported.26

Hepatosplenic T-cell lymphoma pursues an aggressive clinical course. Despite an initial response to chemotherapy, the disease usually relapses. Almost all patients eventually die from the disease, and the median survival is less than 2 years. Because of the poor survival, alternative forms of therapy have to be considered.14, 27, 28, 29, 30, 31 Sporadic examples of favorable response to bone marrow transplantation or treatment with 2′-deoxycoformycin have been reported, but further studies are required to confirm the effectiveness or value of these therapies.32, 33, 34

Pathologic features 

The spleen is usually markedly enlarged, weighing more than 1 kg. The cut surfaces exhibit a uniform beefy red appearance. Histologically, the white pulp is atrophic or lost. The red pulp is expanded by a dense and monotonous infiltrate of medium-sized lymphoma cells, and yet the sinus-pulp cord architecture is not obliterated Fig 6, Fig 7. 28, 29, 30, 31, 35, 36 The lymphoma cells have round, ovoid, or occasionally irregular nuclei, fairly dense chromatin, and a moderate amount of pale to clear cytoplasm (Fig 7B). Mitotic figures are rare. Coagulative necrosis is generally absent.

  • View full-size image.
  • Fig 7. 

    Hepatosplenic T-cell lymphoma with red pulp involvement. (A) Compared with Figure 6, this case shows a much denser neoplastic infiltrate in the red pulp. (B) The sinuses and pulp cords are infiltrated by monotonous medium-sized lymphoma cells.

In the liver, the lymphoma typically involves the sinuses rather than the portal tracts (Fig 8). Bone marrow involvement is very common but often subtle, with lymphoma cells being usually confined within the sinusoids (Fig 9). With progressive disease, the infiltrate in the marrow may become more extensive and interstitial in distribution, accompanied by increase in lymphoma cell size.37

  • View full-size image.
  • Fig 8. 

    Hepatosplenic T-cell lymphoma involving liver. (A) Note the prominent sinusoidal infiltration. There is no involvement of the portal tracts (not shown). (B) Immunostaining for TIA-1 highlights the lymphoma cells.

  • View full-size image.
  • Fig 9. 

    Hepatosplenic T-cell lymphoma with subtle marrow involvement. In a background of normal hematopoietic cells, the sinusoids are packed with medium-sized lymphoma cells (arrows).

Immunohistochemical features 

Hepatosplenic T-cell lymphoma is a neoplasm of non-activated cytotoxic T lymphocyte.13, 30, 36 The lymphoma cells express pan-T markers. The majority of cases express γδ T-cell receptor, which requires the use of fresh or frozen tissue for proper demonstration. Some cases express αβ T-cell receptor instead.15, 16, 17, 18 The lymphoma cells usually do not express CD5, CD4, and CD8, although rare cases may express CD8. Among the cytotoxic markers, TIA-1 is frequently positive but not perforin (Fig 8B).30, 36 The NK-associated marker CD56 is commonly expressed.

Genetic features 

For cases that express γδT-cell receptor, the γ chain T-cell receptor gene is rearranged, while the β chain T-cell receptor gene is either not rearranged or partially rearranged. For cases that express αβ T-cell receptor, both the γ and β chain T-cell receptor genes are rearranged. One common misconception is that demonstration of γ chain T-cell receptor gene rearrangement supports a diagnosis of γδ T-cell lymphoma. This is not true, because T-cell lymphomas expressing αβ T-cell receptor always show rearrangements of the γ chain T-cell receptor gene as well — in normal T cell development, rearrangements of the γ chain in fact precedes that of αβ chain of the T-cell receptor gene. Thus, a firm diagnosis of γδ T-cell lymphoma depends on demonstration of γδ T-cell receptor expression by immunophenotyping, not by molecular analysis.

Isochromosome 7q is a common and recurrent cytogenetic abnormality of hepatosplenic T-cell lymphoma. Other common alterations are trisomy 8 and loss of Y chromosome.29, 30, 31, 36, 38, 39, 40, 41 An increased number of 7q signals was found in three cases with cytologic features of progression, indicating a tendency of hepatosplenic T-cell lymphoma to multiply the i(7)(q10) chromosome during evolution.42

Epstein-Barr virus (EBV) is negative.29, 30 An exception is the series of three Japanese cases reported by Ohshima et al under the designation “hepatosplenic γδ T-cell lymphoma,” in which all cases were EBV positive.43 Although these cases are clinically and immunophenotypically similar to the cases reported in the literature, the differ in that the neoplastic cells are large to medium-sized and exhibit significant nuclear pleomorphism. In the absence of cytogenetic data, it is currently unclear whether such cases with pleomorphic cytologic features should be classified as hepatosplenic T-cell lymphoma.

Problems in diagnosis 

Because the cellular infiltrate in the spleen consists of monotonous medium-sized cells with a moderate amount of cytoplasm, distinction from hairy cell leukemia on morphologic grounds alone is difficult, except that blood lakes are infrequent. Immunohistochemical studies are essential for a firm distinction between hepatosplenic T-cell lymphoma and hairy cell leukemia because the former is a T-cell neoplasm and the latter a B-cell neoplasm.

Peripheral T-cell lymphoma unspecified can also involve the spleen and the liver. Strict criteria should be applied in rendering a diagnosis of hepatosplenic T-cell lymphoma — the infiltrate is predominantly in the red pulp of the spleen, the lymphoid cells should be uniform and medium-sized, and the lymphomas cells should show selective sinusoidal infiltration of the liver.

T-cell large granular lymphocyte leukemia 

Clinical features 

T-cell large granular lymphocyte leukemia is an indolent disease characterized by persistent increase in circulating clonal large granular T-lymphocytes. The proliferated cells are mature T cells that often show a CD4− CD8+ immunophenotype (80% of cases). The cytotoxic marker TIA-1 is usually positive.44, 45

T-cell large granular lymphocyte leukemia is a disease of older adults. The patients are either asymptomatic or present with complications such as infection (caused by chronic neutropenia) and red cell aplasia.44, 45, 46, 47 Up to 30% of patients show serologic and clinical evidence of rheumatoid arthritis. Physical examination is often unrevealing except for moderate splenomegaly. Splenectomy is occasionally performed in patients with a large spleen, but this does not correct the cytopenia.

Pathology of the spleen 

According to the study of Agnarsson et al48 the enlarged spleen weighs 450 to 1650 g, with a median of 600 g. The red pulp is expanded and shows increased cellularity due to selective infiltration of small lymphoid cells in the sinuses and pulp cords (Fig 10). A common accompanying feature is plasmacytosis in the red pulp. In contrast to various lymphoproliferative disorders that infiltrate the red pulp, not only is the white pulp not atrophic but it often shows prominent germinal centers (Fig 10A).48 The diagnosis can be difficult to make in some cases because the neoplastic infiltrate in the red pulp is subtle. Immunostaining for CD3 or CD8 can help to highlight the neoplastic cells (Fig 11).

  • View full-size image.
  • Fig 10. 

    T-cell large granular lymphocyte leukemia involving spleen. (A) At low magnification, the white pulp is hyperplastic and shows prominent germinal centers. The neoplastic infiltrate is confined to the red pulp. (B) In the red pulp, small lymphoid cells with dark round nuclei are dispersed in the sinuses and pulp cords.

  • View full-size image.
  • Fig 11. 

    T-cell large granular lymphocyte leukemia involving spleen. Immunostaining for CD8 highlights the neoplastic cells. The sinus-lining cells are also weakly stained.

S100 protein-positive peripheral T-cell lymphoma 

Clinical features 

S100 protein-positive peripheral T-cell lymphoma, also known as S100-positive T-cell lymphoproliferative disorder, is an uncommon form of peripheral T-cell lymphoma. There are only a handful of reported cases in the literature, but the apparent rarity is probably caused by S100 protein immunostaining being rarely performed in the work-up of lymphomas — such cases are probably simply classified as “peripheral T cell unspecified” without information on S100 expression.

S100 protein-positive peripheral T-cell lymphoma typically affects young patients (12 to 62 years, median 31.5 years), who present with fever, marked splenomegaly and thrombocytopenia, but minimal or no peripheral lymphadenopathy. The disease can become leukemic during the clinical course, and sometimes only after splenectomy. This highly aggressive lymphoma usually causes death within one year.49, 50, 51, 52, 53

Pathologic findings 

The spleen is markedly enlarged, often weighing more than 1 kg. There is diffuse red pulp infiltration by medium-sized or large lymphoma cells with round or slightly irregular nuclei and distinct nucleoli (Fig 12). Besides staining for T lineage markers and S100 protein, the lymphoma cells are commonly CD56 positive. The commonest T-cell subset immunophenotype is CD4−, CD8−, but rare cases can be CD8+ or CD4+. All 4 cases studied for γδ T-cell receptor expression have given negative results.49 The reported association with human herpesvirus 6 requires confirmation by further studies.54

  • View full-size image.
  • Fig 12. 

    S100 protein-positive peripheral T-cell lymphoma. (A) The spleen shows marked expansion of the red pulp. A residual white pulp Malpighian corpuscle is seen in the upper field. (B) The red pulp is infiltrated by medium-sized to large lymphoma cells with distinct nucleoli.

In the liver, the lymphomatous infiltrate is either confined to the sinusoids, or occurs in both the sinusoids and portal tracts. In the lymph node (often intraabdominal), the lymphoma cells show a pure sinusoidal distribution, or show involvement of both the sinusoids and parenchyma.

Peripheral T-cell lymphoma associated with hemophagocytic syndrome 

Hemophagocytic syndrome is a reactive but potentially fatal condition characterized by systemic proliferation of histiocytes, which are actively engaged in phagocytosis of hematopoietic cells.55, 56, 57, 58, 59, 60 The patients often present with high fever, constitutional symptoms, hepatosplenomegaly, and pancytopenia. An abrupt drop of the blood counts in the absence of other obvious causes, and elevated serum lactate dehydrogenase level are particularly characteristic. The most common causes of hemophagocytic syndrome are infections and malignant lymphomas; among the latter, peripheral T-cell and NK-cell lymphomas greatly outnumber B-cell lymphomas.61, 62, 63, 64

Some patients with peripheral T-cell lymphomas are complicated by hemophagocytic syndrome at presentation.64, 65 There is slight or no lymphadenopathy, while splenomegaly is often prominent. The disease usually pursues a highly aggressive clinical course. In patients successfully brought into remission, relapse of lymphoma may be accompanied by reappearance of hemophagocytic syndrome.

The spleen is usually markedly enlarged, weighing over 1 kg. Histologically, there is infiltration of the bone marrow, splenic red pulp and liver by lymphoma cells (often large in size), which are admixed with histiocytosis with active hemophagocytosis. The histiocytes can be distinguished from the lymphoma cells by their smaller, bland-looking, eccentrically-placed nuclei, and fine chromatin (Fig 13). Immunostaining for CD68 can highlight the histiocytes, whereas the lymphoma cells are negative.65

  • View full-size image.
  • Fig 13. 

    Peripheral T-cell lymphoma unspecified associated with hemophagocytic syndrome. Large lymphoma cells (large size, with coarse chromatin) are dispersed in the splenic red pulp. There are many reactive histiocytes with erythrophagocytosis (arrows).

Peripheral T-cell lymphoma with a masking component of epithelioid granuloma 

Some lymphomas involving the spleen are associated with such prominent epithelioid granulomas that the lymphomatous component is obscured (Fig 14). 66, 67, 68 This pattern can be observed in either T-cell or B-cell lymphomas. Immunohistochemical and/or genotypic studies are required for definitive lineage assignment and classification.

  • View full-size image.
  • Fig 14. 

    Peripheral T-cell lymphoma unspecified accompanied by granulomatous reaction. (A) Ill-defined granulomas are seen in the spleen. (B) Atypical lymphoid cells (lymphoma cells) are masked by epithelioid histiocytes.

Aggressive NK-cell leukemia 

Clinical features 

Aggressive NK-cell leukemia most commonly affects young adult patients, who present with fever, systemic symptoms, hepatosplenomegaly, sometimes accompanied by systemic lymphadenopathy. In theperipheral blood, there are circulating large granular lymphocytes which can exhibit variable degrees of atypia. The disease pursues a fulminant clinical course, with most patients dying within days or weeks.69, 70

Pathologic findings 

It is extremely rare to encounter a splenectomy specimen from such patients. At postmortem examination, the spleen is always enlarged. Histologically, the neoplastic infiltrate is located predominantly in the red pulp, but the density of neoplastic cells can be highly variable from area to area (Fig 15). The fibrous trabeculae and blood vessel walls are frequently infiltrated, sometimes in a single-file pattern (Fig 15). They are often admixed with many apoptotic bodies. Commonly there are foci of infarction or coagulative necrosis (Fig 15B).

  • View full-size image.
  • Fig 15. 

    Aggressive NK cell leukemia. (A) The red pulp shows extensive infiltration, with preservation of the sinus-pulp cord architecture. (B) The upper field shows infiltration of the blood vessel wall by neoplastic cells. The lower field shows a large area of necrosis (infarction).

The typical immunophenotype is CD2+, surface CD3-, CD3ϵ+, CD56+, CD16+/-. Cytotoxic markers are positive. Like the normal counterpart (NK cells), the T-cell receptor genes are not rearranged. EBV is almost always positive.69, 70

Differential diagnosis 

Aggressive NK cell leukemia must not be confused with indolent NK cell large granular lymphoproliferative disease, an NK cell proliferation that pursues a nonprogressive course. The main distinguishing features of the latter are lack of clinical symptoms, absence of hepatosplenomegaly and lack of EBV association.

T-cell large granular lymphocyte leukemia is morphologically similar to aggressive NK-cell leukemia in the peripheral blood or bone marrow. It differs from the latter in the following features: indolent clinical course, surface CD3 expression, presence of clonal T-cell receptor gene rearrangements, EBV negativity, less destructive or permeative infiltrate in the spleen, and extreme rarity of necrosis or infarction in the spleen.

Extranodal NK/T cell lymphoma 

Clinical features 

Extranodal NK-/T-cell lymphoma is a putative NK-cell lymphoma that almost always presents in extranodal sites. It affects mostly adults, with a median age of 53 years, and male predominance. Nasal NK-/T-cell lymphoma presents in the nasal cavity and nasopharynx, with variable extension to the surrounding anatomic sites, producing extensive ulcerative lesions (midfacial destructive disease) or a mass lesion. Most patients have stage I or II stage disease. The clinical outcome is variable, with some patients apparently cured by radiation therapy, but others showing early local or systemic relapse despite aggressive treatment. The overall survival rate is about 30%.70, 71, 72

Nasal-type (extranasal) NK-/T-cell lymphoma presents with disease outside the upper aerodigestive tact, with predilection for the skin, gastrointestinal tract, and testis. Most patients have stage III or IV disease, and systemic symptoms are common. The disease pursues a highly aggressive course, with the majority of patients dying within 6 months.70, 72, 73

Pathologic findings 

Clinical evidence of splenic involvement in NK-/T-cell lymphoma is rare, and it is extremely uncommon to encounter a splenectomy specimen in such patients, except when the spleen is removed with other involved intraabdominal organs such as stomach. The following description is based on the limited personal experience of the author. The spleen is of normal size or only slightly enlarged. There is patchy or diffuse infiltration of the red pulp by lymphoma cells (Fig 16). The cytologic spectrum is variable, ranging from small cells to medium-sized and large cells. The nuclei are often irregularly folded. The cytoplasm is usually pale or clear.

  • View full-size image.
  • Fig 16. 

    Nasal NK-/T-cell lymphoma relapsing in the spleen. (A) This field shows involvement of the red pulp. (B) The lymphoma cells are more often located in the pulp cords than the sinuses.

In addition, the lymphoma cells can also colonize some periarteriolar sheaths (Fig 17). The walls of blood vessels often show infiltration by lymphoma cells (Fig 17).

  • View full-size image.
  • Fig 17. 

    Nasal NK-/T-cell lymphoma relapsing in the spleen (same case as Figure 16). (A) Immunostaining for CD3 highlights atypical cells in the periarteriolar sheath, indicating involvement of this zone. (B) Note infiltration of the subintima of blood vessels by lymphoma cells.

Immunocytochemical and genetic features 

The most common immunophenotype is: CD2+, surface CD3−, cytoplasmic CD3ϵ+, CD56+. Cytotoxic markers such as TIA1, granzyme B and perforin are commonly expressed. The T-cell receptor genes are not rearranged, and there is a very strong association with EBV.70, 72, 73

Back to Article Outline

Differential diagnoses 

Infectious mononucleosis can involve the spleen, sometimes presenting as splenic rupture, necessitating splenectomy. The marked increase in lymphoid cells and presence of many large lymphoid cells can lead the unwary to an erroneous diagnosis of lymphoma (Fig 18). This diagnostic difficulty is further compounded by the frequent presence of large lymphoid cells infiltrating the vascular walls (Fig 18). The young age of the patient, a positive Monospot test, presence of a spectrum of lymphoid cells with apparent maturation towards plasma cells, lack of frank nuclear atypia, and presence of a mixture of T and B cells on immunohistochemical studies should led to serious consideration of infectious mononucleosis.

  • View full-size image.
  • Fig 18. 

    Infectious mononucleosis involving spleen. (A) There is a worrisome increase in lymphoid cells, including many activated large lymphoid cells. (B) The lymphoid cells even infiltrate the subintima of blood vessels.

Systemic mast cell disease involving the spleen may mimic T-cell lymphoma histologically because the mast cells form clusters and sheets of medium-sized cells with indented nuclei, clear cytoplasm and inconspicuous granules (Fig 19). This disease can be distinguished from clear cell-rich peripheral T-cell lymphoma by the presence of many admixed eosinophils and delicate to coarse sclerosis. The diagnosis can be readily confirmed by Leder, toluidine blue or Giemsa stain, or by immunoreactivity for tryptase or CD117 (c-kit).

  • View full-size image.
  • Fig 19. 

    Systemic mast cell disease of the spleen may be mistaken for peripheral T-cell lymphoma. The neoplastic cells have medium-sized nuclei and abundant clear cytoplasm. The clues to the correct diagnosis are the admixed eosinophils (most abundant in right field) and the delicate sclerosis.

Back to Article Outline

References 

  1. Neiman RS, Orazi A. Disorders of the Spleen. In: ed 2. Major Problems in Pathology. vol 38:Philadelphia, PA: Saunders; 1999;
  2. Wilkins BS, Wright DH. Illustrated Pathology of the Spleen. Cambridge: Cambridge University Press; 2000;
  3. Neiman RS, Orazi A. Hematolymphoid disorders involving spleen. In:  Knowles DM editors. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;
  4. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin’s lymphoproliferative disorders involving the spleen. Mod Pathol. 1997;10:18–32
  5. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin’s lymphoproliferative disorders involving the spleen. Mod Pathol. 1997;10:18–32
  6. Kraus MD, Fleming MD, Vonderheide RH. The spleen as a diagnostic specimen (A review of 10 years’ experience at two tertiary care institutions). Cancer. 2001;91:2001–2009
  7. Stroup RM, Burke JS, Sheibani K, et al.  Splenic involvement by aggressive malignant lymphomas of B-cell and T- cell types (A morphologic and immunophenotypic study). Cancer. 1992;69:413–420
  8. Falk S, Stutte HJ. Primary malignant lymphomas of the spleen (A morphologic and immunohistochemical analysis of 17 cases). Cancer. 1990;66:2612–2619
  9. Warnke RA, Weiss LM, Chan JK, et al.  Tumors of the Lymph Nodes and Spleen. In: Atlas of Tumor Pathology. Washington D.C: Armed Forces Institute of Pathology; 1995; 3rd series,Fascicle 14
  10. Falk S, Karhoff M, Takeshita M, et al.  Primary pleomorphic T-cell lymphoma of the spleen. Histopathology. 1990;16:191–192
  11. Cuevas E, Ortiz-Hidalgo C, Oliva H, et al.  Primary pleomorphic T-cell lymphoma of the spleen. Leuk Lymphoma. 1993;9:265–267
  12. Sakadamis A, Ballas K, Denga K, et al.  Primary anaplastic large cell lymphoma of the spleen presenting as a splenic abscess. Leuk Lymphoma. 2001;42:1419–1421
  13. Jaffe ES, Ralfkiaer E. Hepatosplenic T-cell lymphoma. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 210–211
  14. Jaffe ES. Hepatosplenic gamma delta T cell lymphoma. In:  Mason DY,  Harris NL editor. Human Lymphoma (Clinical Implications of the REAL Classification). London: Springer-Verlag; 1999;p. 35.1–35.4
  15. Kumar S, Lawlor C, Jaffe ES. Hepatosplenic T-cell lymphoma of alphabeta lineage. Am J Surg Pathol. 2001;25:970–971
  16. Lai R, Larratt LM, Etches W, et al.  Hepatosplenic T-cell lymphoma of alpha-beta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol. 2000;24:459–463
  17. Macon WR, Levy NB, Kurtin PJ, et al.  Hepatosplenic alphabeta T-cell lymphomas (A report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas). Am J Surg Pathol. 2001;25:285–296
  18. Suarez F, Wlodarska I, Rigal-Huguet F, et al.  Hepatosplenic alphabeta T-cell lymphoma (an unusual case in the clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma). Am J Surg Pathol. 2000;24:1027–1032
  19. Ross CW, Schnitzer B, Sheldon S, et al.  Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol. 1994;102:310–315
  20. Salhany KE, Feldman M, Peritt D, et al.  Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. [letter; comment] Blood. 1997;89:3490–3491
  21. Kraus MD, Crawford DF, Kaleem Z, et al.  T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder (A case report). Cancer. 1998;82:983–992
  22. Francois A, Lesesve JF, Stamatoullas A, et al.  Hepatosplenic gamma/delta T-cell lymphoma (A report of two cases in immunocompromised patients, associated with isochromosome 7q). Am J Surg Pathol. 1997;21:781–790
  23. Khan WA, Yu L, Eisenbrey AB, et al.  Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients (Report of two cases and review of literature). Am J Clin Pathol. 2001;116:41–50
  24. Roncella S, Cutrona G, Truini M, et al.  Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. Haematologica. 2000;85:256–262
  25. Wu H, Wasik MA, Przybylski G, et al.  Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol. 2000;113:487–496
  26. Ozaki S, Ogasahara K, Kosaka M, et al.  Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection. J Med Invest. 1998;44:215–217
  27. Yao M, Tien HF, Lin MT, et al.  Clinical and hematological characteristics of hepatosplenic T gamma/delta lymphoma with isochromosome for long arm of chromosome 7. Leuk Lymphoma. 1996;22:495–500
  28. Farcet JP, Gaulard P, Marolleau JP, et al.  Hepatosplenic T-cell lymphoma (Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta). Blood. 1990;75:2213–2219
  29. Wong KF, Chan JK, Matutes E, et al.  Hepatosplenic gamma delta T-cell lymphoma (A distinctive aggressive lymphoma type). [see comments] Am J Surg Pathol. 1995;19:718–726
  30. Cooke CB, Krenacs L, Stetler-Stevenson M, et al.  Hepatosplenic T-cell lymphoma (A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin). Blood. 1996;88:4265–4274 [see comments]
  31. Chang KL, Arber DA. Hepatosplenic gamma delta T-cell lymphoma-not just alphabet soup. Adv Anat Pathol. 1998;5:21–29
  32. Ooi J, Iseki T, Adachi D, et al.  Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica. 2001;86:E25
  33. Grigg AP. 2′-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma. 2001;42:797–799
  34. Iannitto E, Barbera V, Quintini G, et al.  Hepatosplenic gammadelta T-cell lymphoma (Complete response induced by treatment with pentostatin). Br J Haematol. 2002;117:995–996
  35. Sallah S, Smith SV, Lony LC, et al.  Gamma/delta T-cell hepatosplenic lymphoma (review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia). Ann Hematol. 1997;74:139–142
  36. Salhany KE, Feldman M, Kahn MJ, et al.  Hepatosplenic gammadelta T-cell lymphoma (Ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation). Hum Pathol. 1997;28:674–685
  37. Vega F, Medeiros LJ, Bueso-Ramos C, et al.  Hepatosplenic gamma/delta T-cell lymphoma in bone marrow (A sinusoidal neoplasm with blastic cytologic features). Am J Clin Pathol. 2001;116:410–419
  38. Coventry S, Punnett HH, Tomczak EZ, et al.  Consistency of isochromosome 7q and trisomy 8 in hepatosplenic gammadelta T-cell lymphoma (Detection by fluorescence In situ hybridization of a splenic touch-preparation from a pediatric patient). Pediatr Dev Pathol. 1999;2:478–483
  39. Wang CC, Tien HF, Lin MT, et al.  Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma (a new cytogenetic-clinicopathologic entity). Genes Chromosomes Cancer. 1995;12:161–164
  40. Jonveaux P, Daniel MT, Martel V, et al.  Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia. 1996;10:1453–1455
  41. Alonsozana EL, Stamberg J, Kumar D, et al.  Isochromosome 7q (The primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma). Leukemia. 1997;11:1367–1372 [letter]
  42. Wlodarska I, Martin-Garcia N, Achten R, et al.  Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma (isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression). Genes Chromo Cancer. 2002;33:243–251
  43. Ohshima K, Haraoka S, Harada N, et al.  Hepatosplenic gammadelta T-cell lymphoma (Relation to Epstein-Barr virus and activated cytotoxic molecules). Histopathology. 2000;36:127–135
  44. Catovsky D, Matutes E. Leukemias of mature T cells. In:  Knowles DM editors. Neoplastic Hematopathology. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 1589–1602
  45. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control. 1998;5:25–33
  46. Lamy T, Loughran TP. Current concepts (large granular lymphocyte leukemia). Blood Rev. 1999;13:230–240
  47. Loughran TP. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14
  48. Agnarsson BA, Loughran TP, Starkebaum G, et al.  The pathology of large granular lymphocyte leukemia. Hum Pathol. 1989;20:643–651
  49. Hanson CA, Bockenstedt PL, Schnitzer B, et al.  S100-positive, T-cell chronic lymphoproliferative disease (An aggressive disorder of an uncommon T-cell subset). Blood. 1991;78:1803–1813
  50. Chan JK, Ng CS, Chu YC, et al.  S-100 protein-positive sinusoidal large cell lymphoma. Hum Pathol. 1987;18:756–759
  51. Ruco LP, Stoppacciaro A, Barsotti P, et al.  S-100+ lymph node neoplasm. Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis. Virchows Arch A Pathol Anat Histopathol. 1984;404:351–358
  52. Takahashi K, Ohtsuki Y, Sonobe H, et al.  S-100 beta positive T cell leukemia. Blood. 1988;71:1299–1303
  53. Zarate-Osorno A, Raffeld M, Berman EL, et al.  S-100-positive T-cell lymphoproliferative disorder (A case report and review of the literature). Am J Clin Pathol. 1994;102:478–482
  54. Braun DK, Pellett PE, Hanson CA. Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T cell chronic lymphoproliferative disease. J Infect Dis. 1995;171:1351–1355
  55. McKenna RW, Risdall RJ, Brunning RD. Virus associated hemophagocytic syndrome. Hum Pathol. 1981;12:395–398
  56. Risdall RJ. Pathologic anatomy (virus-associated hemophagocytic syndrome). Minn Med. 1980;63:879–880
  57. Risdall RJ, McKenna RW, Nesbit ME, et al.  Virus-associated hemophagocytic syndrome (A benign histiocytic proliferation distinct from malignant histiocytosis). Cancer. 1979;44:993–1002
  58. Wong KF, Chan JK. Reactive hemophagocytic syndrome (A clinicopathologic study of 40 patients in an Oriental population). Am J Med. 1992;93:177–180
  59. Chan JK, Ng CS, Law CK, et al.  Reactive hemophagocytic syndrome (A study of 7 fatal cases). Pathology. 1987;19:43–50
  60. Wong KF, Chan JKC. Hemophagocytic disorders (A review). Hematol Rev. 1991;5:5–37
  61. Wong KF, Chan JK, Lo ES, et al.  A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol. 1996;27:1239–1242
  62. Takahashi N, Miura I, Chubachi A, et al.  A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74:303–308
  63. Su IJ, Hsu YH, Lin MT, et al.  Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer. 1993;72:2019–2027
  64. Chan EY, Pi D, Chan GT, et al.  Peripheral T-cell lymphoma presenting as hemophagocytic syndrome. Hematol Oncol. 1989;7:275–285
  65. Falini B, Pileri S, De Solas I, et al.  Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75:434–444 [see comments]
  66. Braylan RC, Long JC, Jaffe ES, et al.  Malignant lymphoma obscured by concomitant extensive epithelioid granulomas (Report of three cases with similar clinicopathologic features). Cancer. 1977;39:1146–1155
  67. Narang S, Wolf BC, Neiman RS. Malignant lymphoma presenting with prominent splenomegaly (A clinicopathologic study with special reference to intermediate cell lymphoma). Cancer. 1985;55:1948–1957
  68. Brox A, Bishinsky JI, Berry G. Primary non-Hodgkin lymphoma of the spleen. Am J Hematol. 1991;38:95–100
  69. Chan JKC, Wong KF, Jaffe ES, Ralfkiaer E. Aggressive NK-cell leukemia. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 198–200
  70. Chan JK. Natural killer cell neoplasms. Anat Pathol. 1998;3:77–145
  71. Chan JK. Peripheral T-cell and NK-cell neoplasms (An integrated approach to diagnosis). Mod Pathol. 1999;12:177–199
  72. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 204–207
  73. Chan JK, Sin VC, Wong KF, et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56 (A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm). Blood. 1997;89:4501–4513

PII: S0740-2570(03)00013-3

doi:10.1016/S0740-2570(03)00013-3

Seminars in Diagnostic Pathology
Volume 20, Issue 2 , Pages 105-120, May 2003

Article Tools

* Image Usage & Resolution